Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	carnitine O-acyltransferase activity	CROT CPT1A	5.26e-05	6	38	2	GO:0016406
Domain	zf-C2H2_6	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	2.37e-06	314	37	7	PF13912
Domain	Carn_acyltransf	CROT CPT1A	7.97e-05	7	37	2	PF00755
Domain	ACYLTRANSF_C_1	CROT CPT1A	7.97e-05	7	37	2	PS00439
Domain	Carn_acyl_trans	CROT CPT1A	7.97e-05	7	37	2	IPR000542
Domain	ACYLTRANSF_C_2	CROT CPT1A	7.97e-05	7	37	2	PS00440
Domain	-	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	3.23e-04	679	37	7	3.30.160.60
Domain	zf-C2H2	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	3.66e-04	693	37	7	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	3.69e-04	694	37	7	IPR013087
Domain	KRAB	ZNF799 ZNF556 ZNF709 ZNF440 ZNF669	6.62e-04	358	37	5	PS50805
Domain	KRAB	ZNF799 ZNF556 ZNF709 ZNF440 ZNF669	6.62e-04	358	37	5	PF01352
Domain	ZINC_FINGER_C2H2_2	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	7.14e-04	775	37	7	PS50157
Domain	ZINC_FINGER_C2H2_1	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	7.25e-04	777	37	7	PS00028
Domain	KRAB	ZNF799 ZNF556 ZNF709 ZNF440 ZNF669	7.59e-04	369	37	5	SM00349
Domain	KRAB	ZNF799 ZNF556 ZNF709 ZNF440 ZNF669	7.68e-04	370	37	5	IPR001909
Domain	-	SAFB2 SAFB	7.83e-04	21	37	2	1.10.720.30
Domain	Znf_C2H2-like	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	8.36e-04	796	37	7	IPR015880
Domain	SAP	SAFB2 SAFB	8.60e-04	22	37	2	PF02037
Domain	Znf_C2H2	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	8.93e-04	805	37	7	IPR007087
Domain	ZnF_C2H2	TRERF1 ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	9.13e-04	808	37	7	SM00355
Domain	SAP	SAFB2 SAFB	9.41e-04	23	37	2	SM00513
Domain	Spectrin	DMD SPTA1	9.41e-04	23	37	2	PF00435
Domain	SAP	SAFB2 SAFB	1.11e-03	25	37	2	PS50800
Domain	SAP_dom	SAFB2 SAFB	1.11e-03	25	37	2	IPR003034
Domain	Spectrin_repeat	DMD SPTA1	1.50e-03	29	37	2	IPR002017
Domain	Spectrin/alpha-actinin	DMD SPTA1	1.82e-03	32	37	2	IPR018159
Domain	SPEC	DMD SPTA1	1.82e-03	32	37	2	SM00150
Domain	RRM_1	CPEB2 SAFB2 SAFB	8.01e-03	208	37	3	PF00076
Domain	RRM	CPEB2 SAFB2 SAFB	8.99e-03	217	37	3	SM00360
Domain	RRM_dom	CPEB2 SAFB2 SAFB	1.02e-02	227	37	3	IPR000504
Domain	RRM	CPEB2 SAFB2 SAFB	1.05e-02	230	37	3	PS50102
Domain	EGF_3	TENM1 NRXN1 ADAM28	1.12e-02	235	37	3	PS50026
Domain	EGF	TENM1 NRXN1 ADAM28	1.12e-02	235	37	3	SM00181
Domain	MetalloPept_cat_dom	ADAM28 MIPEP	1.12e-02	81	37	2	IPR024079
Domain	-	ADAM28 MIPEP	1.12e-02	81	37	2	3.40.390.10
Pubmed	No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p.	SAFB2 SAFB	1.16e-06	2	38	2	19077293
Pubmed	Low SAFB levels are associated with worse outcome in breast cancer patients.	SAFB2 SAFB	1.16e-06	2	38	2	19137425
Pubmed	Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis?	SAFB2 SAFB	1.16e-06	2	38	2	14587024
Pubmed	SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells.	SAFB2 SAFB	1.16e-06	2	38	2	19901029
Pubmed	Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer Cells.	SAFB2 SAFB	1.16e-06	2	38	2	26273616
Pubmed	Scaffold attachment factor B2 (SAFB2)-null mice reveal non-redundant functions of SAFB2 compared with its paralog, SAFB1.	SAFB2 SAFB	1.16e-06	2	38	2	26092125
Pubmed	Scaffold attachment factor B (SAFB)1 and SAFB2 cooperatively inhibit the intranuclear mobility and function of ERα.	SAFB2 SAFB	1.16e-06	2	38	2	22566185
Pubmed	The enzymatic activity of SR protein kinases 1 and 1a is negatively affected by interaction with scaffold attachment factors B1 and 2.	SAFB2 SAFB	3.48e-06	3	38	2	19674106
Pubmed	SAFB1 interacts with and suppresses the transcriptional activity of p53.	SAFB2 SAFB	6.96e-06	4	38	2	21130767
Pubmed	Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.	SAFB2 SAFB	6.96e-06	4	38	2	16195251
Pubmed	SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor.	SAFB2 SAFB	6.96e-06	4	38	2	12660241
Pubmed	Genomics of the human carnitine acyltransferase genes.	CROT CPT1A	1.74e-05	6	38	2	11001805
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CPEB2 PRICKLE2 DYRK1A SAFB DMD AP2B1 PCBP1 TCP1 SPTA1	1.82e-05	1431	38	9	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	TENM1 SAFB2 CHD2 SAFB DMD NRXN1 RIMS2 AP2B1 SPTA1	1.94e-05	1442	38	9	35575683
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	CPEB2 SAFB2 CHD2 SAFB NKAP PCBP1 TCP1	2.38e-05	807	38	7	22681889
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	IP6K1 SAFB NKAP PCBP1 PATZ1	4.44e-05	361	38	5	26167880
Pubmed	The interactome of the prostate-specific protein Anoctamin 7.	AP2B1 PCBP1 TCP1	5.02e-05	65	38	3	32176628
Pubmed	The molecular chaperone TRiC/CCT binds to the Trp-Asp 40 (WD40) repeat protein WDR68 and promotes its folding, protein kinase DYRK1A binding, and nuclear accumulation.	DYRK1A TCP1	6.35e-05	11	38	2	25342745
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	DMD NRXN1 RIMS2	6.53e-05	71	38	3	33541421
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	SAFB2 CTU2 SAFB AP2B1 PCBP1 WEE1	7.09e-05	653	38	6	33742100
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 SAFB2 DYRK1A NRXN1 AP2B1 PCBP1 PATZ1	7.28e-05	963	38	7	28671696
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	PRICKLE2 CPT1A PCBP1 TCP1 SPTA1	1.01e-04	430	38	5	32581705
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SAFB2 SAFB NKAP PCBP1	1.61e-04	251	38	4	31076518
Pubmed	Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing.	CPEB2 CHD2	1.76e-04	18	38	2	30111840
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 SAFB2 SAFB NKAP PCBP1 WEE1	1.79e-04	774	38	6	15302935
Pubmed	Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.	SAFB PCBP1 TCP1	2.66e-04	114	38	3	31553912
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	SAFB2 DYRK1A AP2B1	2.95e-04	118	38	3	30979931
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SAFB2 CHD2 SAFB CPT1A PCBP1 PATZ1 SPTA1	4.46e-04	1294	38	7	30804502
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	SAFB2 SAFB PCBP1 TCP1	4.55e-04	330	38	4	33301849
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	SAFB2 CHD2 SAFB NKAP PCBP1 TCP1 POLR1H	4.97e-04	1318	38	7	30463901
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	DYRK1A NKAP PAN3 NRXN1 AP2B1 WEE1 PATZ1	5.04e-04	1321	38	7	27173435
Pubmed	Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2.	DMD CILP	5.30e-04	31	38	2	16140986
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	DYRK1A SAFB PCBP1 TCP1	6.12e-04	357	38	4	37059091
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TRERF1 NKAP CPT1A PCBP1 PATZ1	7.00e-04	655	38	5	35819319
Pubmed	Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling.	AP2B1 PCBP1 TCP1	7.29e-04	161	38	3	36398662
Pubmed	An investigation into the human serum "interactome".	SAFB2 CROT DMD	7.42e-04	162	38	3	15174051
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	NKAP PAN3 AP2B1 PCBP1 TCP1	8.18e-04	678	38	5	30209976
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	AP2B1 PCBP1 TCP1 WEE1	9.43e-04	401	38	4	25852190
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	SAFB2 SAFB CPT1A AP2B1 TCP1	9.49e-04	701	38	5	30196744
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF799 ZNF440 ZNF669	1.02e-03	181	38	3	37372979
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	SAFB AP2B1 PCBP1 PATZ1	1.03e-03	411	38	4	35182466
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	AP2B1 TCP1 PATZ1	1.04e-03	182	38	3	31067453
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SAFB2 CHD2 SAFB PAN3 NRXN1 AP2B1	1.05e-03	1082	38	6	38697112
Pubmed	A non-proteolytic role for ubiquitin in deadenylation of MHC-I mRNA by the RNA-binding E3-ligase MEX-3C.	SAFB2 AP2B1	1.07e-03	44	38	2	26471122
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	SAFB2 ZNF799 SAFB ZNF556 ZNF709 ZNF440	4.62e-05	797	38	6	chr19p13
Cytoband	Xq25	TENM1 TEX13C	5.36e-04	41	38	2	Xq25
Cytoband	Ensembl 112 genes in cytogenetic band chrXq25	TENM1 TEX13C	7.35e-04	48	38	2	chrXq25
Cytoband	19p13.2	ZNF799 ZNF709 ZNF440	9.08e-04	229	38	3	19p13.2
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF799 ZNF556 ZNF709 PATZ1 ZNF440 ZNF669	1.25e-04	718	21	6	28
GeneFamily	RNA binding motif containing	CPEB2 SAFB2 SAFB	1.83e-03	213	21	3	725
Coexpression	GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	RNF144B IP6K1 PAN3 AP2B1 TCP1	6.18e-06	186	37	5	M8175
ToppCell	facs-Bladder-nan-3m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF144B CROT PAN3 CPT1A WEE1	6.33e-07	194	38	5	e74cd8cf3763f6adbfd1c269a886a806049714cf
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TENM1 PRICKLE2 DMD ADAM28	1.41e-05	173	38	4	f8e3dded726bb3a6c24bfedf8c6732bb46262308
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TENM1 PRICKLE2 DMD ADAM28	1.54e-05	177	38	4	e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell	PCW_10-12-Neuronal-Neuronal_postreplicative\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NPR3 DMD NRXN1 RIMS2	1.68e-05	181	38	4	1aebb62ed4439db444ee9d30688212b86ee3d9ef
ToppCell	PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NPR3 DMD NRXN1 RIMS2	1.68e-05	181	38	4	6aee2ddee4790250ef3b2ef0038bd9839925c995
ToppCell	PCW_10-12-Neuronal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NPR3 DMD NRXN1 RIMS2	1.68e-05	181	38	4	381b553e2cae65ce6be100662a5f9f963353840c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM1 DMD NRXN1 SPTA1	1.79e-05	184	38	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM1 DMD NRXN1 SPTA1	1.79e-05	184	38	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM1 DMD NRXN1 SPTA1	1.79e-05	184	38	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 PRICKLE2 RIMS2 WEE1	1.99e-05	189	38	4	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 PRICKLE2 RIMS2 WEE1	1.99e-05	189	38	4	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area\|World / Primary Cells by Cluster	NPR3 DMD NRXN1 RIMS2	2.34e-05	197	38	4	79b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33\|World / Primary Cells by Cluster	NPR3 DMD NRXN1 RIMS2	2.34e-05	197	38	4	d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	PRICKLE2 DYRK1A DMD PAN3	2.39e-05	198	38	4	1996373bdccc55aac347d349bd22f6aad6d0c668
Computational	Neighborhood of RAD21	DYRK1A PCBP1 TCP1	4.11e-05	37	20	3	GCM_RAD21
Computational	Neighborhood of DDX5	DYRK1A PCBP1 TCP1	2.24e-04	65	20	3	GCM_DDX5
Drug	TAT-59	SAFB2 SAFB DMD	2.37e-06	16	38	3	CID003034829
Drug	butyl benzyl phthalate	SAFB2 DYRK1A SAFB	2.06e-05	32	38	3	CID000002347
Drug	RU 58668	TRERF1 SAFB2 SAFB	2.26e-05	33	38	3	CID000119604
Disease	autism spectrum disorder (implicated_via_orthology)	DYRK1A CHD2 NRXN1 RIMS2	3.51e-05	152	36	4	DOID:0060041 (implicated_via_orthology)
Disease	intellectual disability (is_implicated_in)	DYRK1A DMD	6.16e-04	30	36	2	DOID:1059 (is_implicated_in)
Disease	Malignant neoplasm of breast	TRERF1 TENM1 CTU2 DMD CPT1A TCP1	1.75e-03	1074	36	6	C0006142
Disease	schizophrenia (implicated_via_orthology)	NRXN1 RIMS2	3.13e-03	68	36	2	DOID:5419 (implicated_via_orthology)
Disease	susceptibility to mononucleosis measurement	CPEB2 DMD	3.23e-03	69	36	2	EFO_0008403
Disease	Epilepsy, Cryptogenic	DYRK1A CHD2	4.52e-03	82	36	2	C0086237
Disease	Awakening Epilepsy	DYRK1A CHD2	4.52e-03	82	36	2	C0751111
Disease	Aura	DYRK1A CHD2	4.52e-03	82	36	2	C0236018
Disease	Autism Spectrum Disorders	CHD2 NRXN1	4.85e-03	85	36	2	C1510586
Disease	Neurodevelopmental Disorders	DYRK1A CHD2	5.77e-03	93	36	2	C1535926

Protein segments in the cluster

Peptide	Gene	Start	Entry
SGTFTHRQGHIYMEM	AP2B1	726	P63010
LRVAGTMAHEMGHNF	ADAM28	331	Q9UKQ2
QHMYRLAMTGSGIDR	CPT1A	641	P50416
THEGYMMDLTAHQGR	DMD	381	P11532
YMTEGHLTMRQGADR	DYRK1A	731	Q13627
MLVAHRHGMTSGDYA	NPR3	271	P17342
MGSAGRLHYLAMTAE	RNF144B	1	Q7Z419
VARQQSHFAMMHGGT	PCBP1	241	Q15365
MHSHSTYMQARGHIV	HSFY1	301	Q96LI6
GVHMAGRTSGAHMNA	AQP7P3	81	A6NL99
MTGQMAGDHTRLEFH	NRXN1	831	Q9ULB1
DRMSYHVRSHDGSVG	PATZ1	396	Q9HBE1
MTGHYNTISRMDRHR	RIMS2	1051	Q9UQ26
HGRMHQSFDFDGGMA	PRICKLE2	636	Q7Z3G6
FHAGGETMMSRHFND	PAN3	571	Q58A45
GAMHGRDHRRTGNMG	CPEB2	141	Q7Z5Q1
MDAHRSGSYRPNNMS	CHD2	1681	O14647
FRRMSDHRPAMGYHG	CHD2	1741	O14647
HQVGGHSSMMRYDDH	IP6K1	31	Q92551
LHMARAHGYSKVMTG	CTU2	251	Q2VPK5
GYVMSGSRHRRMEAV	NKAP	351	Q8N5F7
TAMTRHFYHGRTETM	CROT	441	Q9UKG9
EHRMFMGEAYSAATG	MROH5	76	Q6ZUA9
GHEGMAYHTRQMRSA	POLR1H	91	Q9P1U0
HGRSQMESMLISGYA	TCP1	201	P17987
MHSVSRHGYQLEMGS	TENM1	91	Q9UKZ4
EGSRSMMGEREGQHY	SAFB	766	Q15424
MMGEREGQHYPERHG	SAFB	771	Q15424
RFGHVYMGNSRVSMT	CILP	506	O75339
SVRRHMVMHSGDGPY	ZNF440	186	Q8IYI8
GRGLRYIHSMSLVHM	WEE1	411	P30291
EMGHAMHSMLGRTRY	MIPEP	496	Q99797
MHSMLGRTRYQHVTG	MIPEP	501	Q99797
FRAHVMMHAGGRPYE	ZNF556	246	Q9HAH1
LGSFQRHMVMHTRDG	ZNF799	321	Q96GE5
MAMNFGDHASGFRHD	TEX13C	1	A0A0J9YWL9
GSRPMMGDHRDGQHY	SAFB2	786	Q14151
HMQQYMDPRGRSHLS	SPTA1	2391	P02549
IYHTTFRGHMRMHTG	ZNF709	206	Q8N972
GVRRHMIMHSGNPAY	ZNF669	236	Q96BR6
ALNGHMRSHGGMRAS	TRERF1	526	Q96PN7